The Oncology Institute, Inc.
NASDAQThe Oncology Institute enters the back half of June with a rare combination: a stock up 28% over the past month, analysts actively raising targets, and a lending market so loose it barely registers as a short thesis at all. The analyst story is the most active thread this week. Needham lifted its target from $5.00 to $7.00 today — a 40% jump — while keeping its Buy rating. That…
Snapshot as of 18 Jun 2026
The Oncology Institute enters the back half of June with a rare combination: a stock up 28% over the past month, analysts actively raising targets, and a lending market so loose it barely registers as a short thesis at…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TOI — free to start on ORTEX.
Sign up for free →Open TOI on ORTEX